Latest News
-
Starving leukemia cells by targeting amino acids
March 11, 2019Cancer cells consume sugar at a higher rate than healthy cells, but they’re also hungry for amino acids, the building blocks of proteins and other biomolecules. Researchers at Winship Cancer Institute of Emory University have discovered a way to exploit that hunger to selectively block the growth of leukemias. The results were published online Monday, March 11 in Nature Metabolism.
-
Emory continues high rankings in NIH research funding with Pediatrics ranking 4th
March 11, 2019The Blue Ridge Institute for Medical Research has posted its 2018 rankings of schools and departments by NIH funding, and Emory once again scores among the nation’s most elite universities. Overall, Emory University is ranked 18th in the nation in NIH institutional funding.
-
Sifting through signs of inflammation to analyze causes of Crohn’s disease
March 11, 2019When studying Crohn's disease, an inflammatory disorder of the gastrointestinal tract, a challenge is separating out potential causes from the flood of systemic inflammation inherent in the condition. Researchers led by Subra Kugathasan, MD recently published an analysis that digs under signs of inflammation, in an effort to assess possible causes.
-
A New Treatment Can Relieve Food Allergies, But Few Doctors Offer It
March 05, 2019Yet for many, to be able to tolerate even one or two whole peanuts without symptoms is life-changing. "It provides that additional margin of safety," says Dr. Brian Vickery, an allergist-immunologist at Emory University. "By undergoing this type of treatment, they can move around in the world with more peace of mind."
-
First genetic clue for elusive pediatric liver disease
March 05, 2019The story of Meredith Brown, a biliary atresia patient wouldn’t be alive today if not for the transplant team at Children’s Healthcare of Atlanta, which includes Emory doctors and researchers.
-
Brian Vickery, MD: Setting Dosing Standards for Immunotherapy Trials
February 26, 2019Not all practices should be adopted from groundbreaking work. In an interview with MD Magazine® while at the American Academy of Allergy, Asthma & Immunology (AAAAI) 2019 Annual Meeting in San Francisco, CA, this week, Brian Vickery, MD, explained how a poor, unevidenced dosing regimen has burdened recent phase 3 food allergy immunotherapy trials.
-
Diet low in added sugars significantly improves fatty liver disease in children
January 23, 2019Miriam Vos and colleagues at Emory, University of California/San Diego, and Children's Healthcare of Atlanta conducted a randomized clinical trial of a dietary intervention in adolescent boys with nonalcoholic fatty liver disease.
-
eIRB Go-Live at Children’s Healthcare of Atlanta
January 15, 2019The Children’s IRB is moving to an electronic system for all submissions starting on Monday, February 4, 2019